HomeCompareFOVAX vs EQR

FOVAX vs EQR: Dividend Comparison 2026

FOVAX yields 17.07% · EQR yields 5.87%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 FOVAX wins by $13.1K in total portfolio value
10 years
FOVAX
FOVAX
● Live price
17.07%
Share price
$23.09
Annual div
$3.94
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$60.9K
Annual income
$4,864.82
Full FOVAX calculator →
EQR
EQR
● Live price
5.87%
Share price
$59.15
Annual div
$3.47
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$47.8K
Annual income
$5,475.61
Full EQR calculator →

Portfolio growth — FOVAX vs EQR

📍 FOVAX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodFOVAXEQR
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, FOVAX + EQR cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
FOVAX pays
EQR pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

FOVAX
Annual income on $10K today (after 15% tax)
$1,451.18/yr
After 10yr DRIP, annual income (after tax)
$4,135.10/yr
EQR
Annual income on $10K today (after 15% tax)
$499.01/yr
After 10yr DRIP, annual income (after tax)
$4,654.27/yr
At 15% tax rate, EQR beats the other by $519.17/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of FOVAX + EQR for your $10,000?

FOVAX: 50%EQR: 50%
100% EQR50/50100% FOVAX
Portfolio after 10yr
$54.4K
Annual income
$5,170.21/yr
Blended yield
9.51%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

FOVAX
No analyst data
EQR
Analyst Ratings
16
Buy
28
Hold
2
Sell
Consensus: Hold
Price Target
$70.35
+18.9% upside vs current
Range: $63.00 — $78.50
Altman Z
1.8
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

FOVAX buys
0
EQR buys
0
No recent congressional trades found for FOVAX or EQR in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricFOVAXEQR
Forward yield17.07%5.87%
Annual dividend / share$3.94$3.47
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.8%
Portfolio after 10y$60.9K$47.8K
Annual income after 10y$4,864.82$5,475.61
Total dividends collected$31.8K$23.0K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: FOVAX vs EQR ($10,000, DRIP)

YearFOVAX PortfolioFOVAX Income/yrEQR PortfolioEQR Income/yrGap
1← crossover$12,407$1,707.28$11,380$679.82+$1.0KFOVAX
2$15,255$1,979.69$13,014$837.25+$2.2KFOVAX
3$18,598$2,274.90$14,961$1,036.20+$3.6KFOVAX
4$22,492$2,591.94$17,297$1,289.22+$5.2KFOVAX
5$26,996$2,929.53$20,121$1,613.15+$6.9KFOVAX
6$32,172$3,286.13$23,561$2,030.84+$8.6KFOVAX
7$38,084$3,659.97$27,783$2,573.54+$10.3KFOVAX
8$44,799$4,049.10$33,013$3,284.39+$11.8KFOVAX
9$52,386$4,451.44$39,547$4,223.51+$12.8KFOVAX
10$60,918$4,864.82$47,791$5,475.61+$13.1KFOVAX

FOVAX vs EQR: Complete Analysis 2026

FOVAXStock

The fund seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its net assets (including investment borrowings) in equity securities of U.S. listed companies with small market capitalizations ("Small-Cap Companies") at the time of investment. Currently, a company will be considered to be a Small-Cap Company if its market capitalization at the time of purchase is within the range of companies in the Russell 2000 Index or the S&P SmallCap 600 Index during the most recent 12-month period (based on month-end data).

Full FOVAX Calculator →

EQRREIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →
📬

Get this FOVAX vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

FOVAX vs SCHDFOVAX vs JEPIFOVAX vs OFOVAX vs KOFOVAX vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.